Abstract:Main Points Neuraminidase‐induced neuroinflammation triggers long‐term microglial priming. Moderate colony stimulating factor 1 (CSF1R) inhibition reverts microglial priming to a homeostatic phenotype, with only a partial and transient depletion of the microglial population. In acute neuroinflammation, microglia activate transiently, and return to a resting state later on. However, they may retain immune memory of such event, namely priming. Primed microglia are more sensitive to new stimuli and develop exacerbated responses, representing a risk factor for neurological disorders with an inflammatory component. Strategies to control the hyperactivation of microglia are, hence, of great interest. The receptor for colony stimulating factor 1 (CSF1R), expressed in myeloid cells, is essential for microglia viability, so its blockade with specific inhibitors (e.g. PLX5622) results in significant depletion of microglial population. Interestingly, upon inhibitor withdrawal, new naïve microglia repopulate the brain. Depletion‐repopulation has been proposed as a strategy to reprogram microglia. However, substantial elimination of microglia is inadvisable in human therapy. To overcome such drawback, we aimed to reprogram long‐term primed microglia by CSF1R partial inhibition. Microglial priming was induced in mice by acute neuroinflammation, provoked by intracerebroventricular injection of neuraminidase. After 3‐weeks recovery, low‐dose PLX5622 treatment was administrated for 12 days, followed by a withdrawal period of 7 weeks. Twelve hours before euthanasia, mice received a peripheral lipopolysaccharide (LPS) immune challenge, and the subsequent microglial inflammatory response was evaluated. PLX5622 provoked a 40%–50% decrease in microglial population, but basal levels were restored 7 weeks later. In the brain regions studied, hippocampus and hypothalamus, LPS induced enhanced microgliosis and inflammatory activation in neuraminidase‐injected mice, while PLX5622 treatment prevented these changes. Our results suggest that PLX5622 used at low doses reverts microglial priming and, remarkably, prevents broad microglial depletion.

Colony-Stimulating Factor 1 Receptor Signaling Is Necessary for Microglia Viability, Unmasking a Microglia Progenitor Cell in the Adult Brain

Microglia Impede Oligodendrocyte Generation in Aged Brain

Abstract 085: Loss of Microglia Enhances Neuronal Activity in the Sympathetic Paraventricular Nucleus

Proximal recolonization by self-renewing microglia re-establishes microglial homeostasis in the adult mouse brain.

Colony-stimulating factor 1 receptor inhibition prevents microglial plaque association and improves cognition in 3xTg-AD mice

Colony-stimulating factor 1 receptor (CSF1R) signaling in injured neurons facilitates protection and survival

Inhibition of IL-34 Unveils Tissue-Selectivity and Is Sufficient to Reduce Microglial Proliferation in a Model of Chronic Neurodegeneration

Function of CSF1 and IL34 in Macrophage Homeostasis, Inflammation, and Cancer.

Long‐term reprogramming of primed microglia after moderate inhibition of CSF1R signaling

Adult microglial TGFβ1 is required for microglia homeostasis via an autocrine mechanism to maintain cognitive function in mice

Deletion of a Csf1r enhancer selectively impacts CSF1R expression and development of tissue macrophage populations

Typical development of synaptic and neuronal properties can proceed without microglia

Typical development of synaptic and neuronal properties can proceed without microglia in the cortex and thalamus

Effects of long-term and brain-wide colonization of peripheral bone marrow-derived myeloid cells in the CNS

Mitochondrial respiration in microglia is essential for response to demyelinating injury but not proliferation

CSF-1 controls cerebellar microglia and is required for motor function and social interaction

Microglia contribute to normal myelinogenesis and to oligodendrocyte progenitor maintenance during adulthood

Depletion of microglia exacerbates injury and impairs function recovery after spinal cord injury in mice

Microglial repopulation reverses cognitive and synaptic deficits in an Alzheimer's disease model by restoring BDNF signaling

Lifelong absence of microglia alters hippocampal glutamatergic networks but not synapse and spine density

On the utility of CSF1R inhibitors